Adiposity/physiology ; Adult ; Body Mass Index ; Cross-Sectional Studies ; Female ; Humans ; Intra-Abdominal Fat/metabolism ; Korea ; Lipoproteins/metabolism ; Lipoproteins, LDL/blood* ; Male ; Middle Aged ; Obesity/blood ; Obesity/metabolism* ; Overweight/blood* ; Overweight/metabolism*
Keywords
Lipoprotein subfraction ; Overweight ; Small dense low-density lipoprotein (LDL) ; Visceral to subcutaneous adipose tissue ratio (VAT/SAT ratio)
Abstract
OBJECTIVE: The purposes of this study were (1) to determine the association between lipoprotein subfraction profiles and metabolically healthy overweight (MHO) phenotype, as defined by visceral adiposity; and (2) to identify the strongest predictor of metabolic health among the lipoprotein measurements.
MATERIALS/METHODS: This cross-sectional study was comprised of 462 overweight patients, who were classified as MHO or non-MHO based on their visceral adipose tissue (VAT) area to subcutaneous adipose tissue area (SAT) ratio (VAT/SAT ratio). Serum lipoprotein subfraction analyses and other metabolic parameters were measured.
RESULTS: Among the overweight participants, two hundred fifty-five individuals (53.7%) had the MHO phenotype. After adjusting for age, sex, medication, lifestyle factors, and confounding metabolic characteristics, the non-MHO group showed significantly higher lipid levels and a greater prevalence of unfavorable lipid profiles. LDL subclass pattern type B was the most significant predictor of the non-MHO phenotype (odds ratio 2.70; 95% CI 1.55-4.69), while serum LDL cholesterol level was not a significant predictor of the non-MHO phenotype.
CONCLUSIONS: Lipoprotein subfraction particle measurements were significantly associated with the non-MHO phenotype and a higher VAT/SAT ratio, with small dense LDL predominance being the most significant predictor of MHO phenotype. These findings will help identify MHO and non-MHO phenotypes and perhaps lead to a development of cost-effective individualized treatments.